In line with these observations, TGF-β-activated versican expression in CAFs has been shown to induce the remodeling of ECM and ovarian cancer cell invasion by upregulation and binding to CD44 in ovarian cancer cells (148). Here, TGFB1 is linked to ovarian cancer.